Secondary Glioblastoma
1 clinical trials · Condition
◉ Watch Secondary Glioblastoma
| Record | Firm | Date |
|---|---|---|
| A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden (NCT04145115) | National Cancer Institute (NCI) | 2020-12-24 |
Track Secondary Glioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.